P-Cumarzuur-ethylester (standaard)

Benazeprilat (Standard) is the analytical standard of Benazeprilat. This product is intended for research and analytical applications. Benazeprilat is an orally active and the active metabolite of benazepril, a carboxyl-containing ACE inhibitor with antihypertensive activity. Benazepril is a well-established antihypertensive agent, both in monoresearch and in combination with other classes of drugs including thiazide diuretics and calcium channel blockers. Benazepril is a first-line research in reducing various pathologies associated with CV risk and secondary end-organ damage[1][2][3].

7362-39-2

Ethyl (E) -p-hydroxycinnamate (Standard) ; Ethyl trans-4-hydroxycinnamate (Standard)

12352005

Drug Metabolite; Reference Standards

Metabolic Enzyme/Protease; Others

Inflammation/Immunology

CCOC(/C=C/C1=CC=C(O)C=C1)=O

C11H12O3

192.21

[1]T. Silva, et al. Hydroxycinnamic acid as a novel scaffold for the development of cyclooxygenase-2 inhibitors. RSC Advances. Issue 72, 2015.|[2]Pragasam SJ, et al. Immunomodulatory and anti-inflammatory effect of p-coumaric acid, a common dietary polyphenol on experimental inflammation in rats. Inflammation. 2013 Feb;36 (1) :169-76.

Room temperature

http://file.medchemexpress.com/batch_PDF/HY-N3103R/

Reference Standards